Bluebird Bio | DEBITO



DEBITO Cambiamento Data
Agios Pharmaceuticals USD 44.52M 4.24M 2025-09
Alnylam Pharmaceuticals USD 1.31B 11.39M 2025-09
Amgen USD 54.59B 1.62B 2025-09
Arrowhead Research USD 366.28M 13.25M 2025-09
Biogen USD 6.29B 1.7M 2025-12
BioMarin Pharmaceutical USD 604.24M 375K 2025-09
Gilead Sciences USD 24.94B 5M 2025-09
Incyte USD 40.41M 855K 2025-12
Ionis Pharmaceuticals USD 1.23B 192.99M 2025-09
Moderna USD 734M 7M 2025-09
Nektar Therapeutics USD 0 0 2022-06
Novartis USD 32.64B 1.37B 2025-06
Pfizer USD 60.85B 78M 2025-09
PTC Therapeutics USD 286.32M 306K 2025-09
Regeneron Pharmaceuticals USD 2.71B 400K 2025-09
Sangamo BioSciences USD 0 0 2022-06
Sarepta Therapeutics USD 1.35B 215.59M 2025-06
Tectonic Therapeutic USD 876K 115K 2024-12
Ultragenyx Pharmaceutical USD 33.83M 2.46M 2025-09
Vertex Pharmaceuticals USD 1.83B 307.4M 2025-09


Bluebird Bio DEBITO - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.